Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in J Neurosci

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    January 2018
  1. PEARSON C
    A Therapeutic Link between Astrogliosis and Remyelination in a Mouse Model of Multiple Sclerosis.
    J Neurosci. 2018;38:29-31.
    PubMed     Text format    


    November 2017
  2. HU X, Huang F, Wang ZJ
    CaMKIIalpha mediates the effect of IL-17 to promote ongoing spontaneous and evoked pain in multiple sclerosis.
    J Neurosci. 2017 Nov 16. pii: 2666-17. doi: 10.1523/JNEUROSCI.2666-17.2017.
    PubMed     Text format     Abstract available


    September 2017
  3. STONE S, Jamison S, Yue Y, Durose W, et al
    NF-kappaB Activation Protects Oligodendrocytes against Inflammation.
    J Neurosci. 2017;37:9332-9344.
    PubMed     Text format     Abstract available


  4. QIN J, Sikkema AH, van der Bij K, de Jonge JC, et al
    GD1a overcomes inhibition of myelination by fibronectin via activation of protein kinase A. Implications for multiple sclerosis.
    J Neurosci. 2017 Sep 12. pii: 0103-17. doi: 10.1523/JNEUROSCI.0103-17.2017.
    PubMed     Text format     Abstract available


    August 2017
  5. FELIU A, Bonilla Del Rio I, Carrillo-Salinas FJ, Hernandez-Torres G, et al
    2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
    J Neurosci. 2017;37:8385-8398.
    PubMed     Text format     Abstract available


    January 2017
  6. MANDOLESI G, De Vito F, Musella A, Gentile A, et al
    miR-142-3p Is a Key Regulator of IL-1beta-Dependent Synaptopathy in Neuroinflammation.
    J Neurosci. 2017;37:546-561.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: